TARSUS PHARMACEUTICALS INC
TARSNASDAQ🏆 #1429 by market capEarnings Nov 2US Equity
$69.46▲ $1.74 (+2.51%)
Market closed · at close1h—
24h▲ 2.5%
7d▲ 13.5%
14d▲ 18.9%
30d▲ 17.3%
1y▲ 35.2%
🏦Market Cap
$2.99B
Small Cap
📈Revenue Growth (YoY)
+105.2%
High Growth
📊Gross Margin
93.3%
High
💵FCF Margin
14.3%
Healthy
⚖️P/S Ratio
4.9x
Fair
Otter Score
58
Weak
Earnings
Q3 · 2026Reported 2026-08-06Earnings Per Share
Actual
-0.43
Expected
-0.19
miss
−124.20%
YoY +10.40%
Revenue
Actual
$173.91M
Expected
$169.65M
beat
+2.50%
YoY +69.40%
Consensus estimates
Recent quarters
Q3 2026
-0.43
miss
Q2 2026
-0.16
beat
Q1 2026
-0.20
miss
Q4 2025
-0.30
beat